John Whelan: Why Irish firms face greater challenges doing business in Nigeria
Guinness, an African favourite since the 1960s, has had to weather Nigeria's exchange rate volatility for decades.
Last week GSK, one of the world’s leading pharmaceutical and healthcare companies, employing 1,800 people in its Dungarvan, Cork, Sligo, and Dublin plants, announced plans to stop doing business directly in Nigeria, putting the brakes on its extensive activity in Africa’s largest economy after over half a century of having its own subsidiary there.
Although GSK has not specified a reason for the move, in common with many Irish companies trading there, it has found it increasingly difficult to handle foreign currency payment issues. GSK announced that it will move the distribution of its products to a third-party Nigerian company, which is the route followed by many of its peers.
You have reached your article limit. Already a subscriber? Sign in
Save €40 on an Annual Subscription.
Continue reading within unlimited digital access and exclusive subscriber benefits.
Cancel anytime
Read
Listen
Watch
Play
Latest
- House Republicans quash effort to impeach US defence secretary Hegseth
- Contractor appointed as next stage of Azzurri Walsh Park’s redevelopment takes shape
- SThe Gaelic Football Show: Saturday night lights, Michael Murphy's legacy, are coaching conferences worth it?
- Kevin Long's Cork City return imminent as centre-half quits Waterford
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.
Revoiced
Newsletter
Had a busy week? Sign up for some of the best reads from the week gone by. Selected just for you.
Most Read
Tuesday, November 10, 2026 - 6:00 PM
Tuesday, November 10, 2026 - 12:00 PM
Tuesday, November 10, 2026 - 5:00 PM






